Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas

American Journal of Pathology

Volumn 148, Issue 4, 1996, Pages 1275-1282

  Goldman, David ^a   Cho, Youngsoo ^a   Zhao, Meng Liang ^a   Casadevall, Arturo ^a   Lee, Sunhee C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; IMMUNOHISTOCHEMISTRY; LUNG GRANULOMA; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM; VASCULAR ENDOTHELIUM;

ANIMALS; CRYPTOCOCCOSIS; EPITHELIUM; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOMA; INTERFERON TYPE II; LUNG DISEASES, FUNGAL; MACROPHAGES; MALE; NEUTROPHILS; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED F344; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029871993     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Diamond RD. Cryptococcus neoformans Practice and Principles of Infectious Diseases Edited by GL Mandell, RG Douglas Jr, JE Bennett JE New York, Churchill Livingstone, 1990, pp 1980-1989
2. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ: Cryptococcal disease in patients with the acquired immunodeficiency syndrome diagnostic features and outcome of treatment. Ann Intern Med 1986, 104:234-240
3. + T cells J Exp Med 1991, 173:755-758
4. + T cells. J Exp Med 1991, 173: 793-800
5. Goldman D, Lee SC, Casadevall A: Pathogenesis of pulmonary cryptococcosis in the rat Infect Immun 1994, 62:4755-4761
6. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6 3051-3064
7. Nathan C, Xie Q-W Nitric oxide synthases. roles, tolls, and controls. Cell 1994, 78:915-918
8. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q-W, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650
9. Green SJ, Scheller LF, Marletta MA, Seguin MC, Klotz FW, Slayter M, Nelson BJ, Nacy CA: Nitric oxide cytokine regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett 1994, 43:87-94
10. Alspaugh JA, Granger DL: Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effector of macrophage-mediated cytostasis Infect Immun 1991, 59:2291-2296
11. Cameron ML, Granger DL, Weinberg JB, Kozumbo WJ, Koren HS Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis 1990, 142:1313-1319
12. Blasi E, Barluzzi R, Mazzolla R, Tancini B, Saleppico S, Puliti M, Pitzurra L, Bistoni F: Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol 1995, 58:111-116
13. Lee SC, Dickson DW, Brosnan CF, Casadevall A Human astrocytes inhibit the growth of Cryptococcus neoformans by a nitric oxide-mediated mechanism. J Exp Med 1994, 180:365-369
14. Cuevas EC, Bateman AC, Wilkins BS, Johnson PA, Williams JH, Lee AHW, Jones DB, Wright DH: Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol 1994, 47:448-452
15. Buttery LDK, Evans TJ, Springall DR, Carpenter A, Cohen J, Polak JM Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest 1994, 71:755-764
16. Stenger S, Thuring H, Rollinghoff M, Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 1994, 180:783-793
17. Vodovotz Y, Bogdan C, Paik J, Xie Q-W, Nathan C: Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J Exp Med 1993, 178:605-613
18. Naslund PK, Miller NC, Granger DL. Cryptococcus neoformans fails to induce nitric oxide synthesis in primed murine macrophage-like cells. Infect Immun 1995, 63 1298-1304
19. Mozaffarian N, Berman JW, Casadevall A: Immune complexes increase nitric oxide production by interferon-γ stimulated murine macrophage-like J774. 16 cells J Leukocyte Biol 1995, 57:657-662
20. Chan J, Xing RS, Magliozzo RS, Bloom BR: Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992, 175:1111-1122
21. Boockvar KS, Granger DL, Poston RM, Maybodi M, Washington MK, Hibbs JBJ, Kurlander RL: Nitric oxide production during murine listertosis is protective. Infect Immun 1994, 62:1089-1100
22. + T cells. J Exp Med 1994, 180:353-358
23. Albina JE, Abate JA, Henry WL. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-γ in the induction of nitric oxide-synthesizing pathway J Immunol 1991, 147 144-149
24. Mills CD: Molecular basis of "suppressor" macrophages: arginine metabolism via the nitric oxide synthase pathway. J Immunol 1991, 146:2719-2723
25. Denis M: Human monocytes/macrophages: NO or no NO? J Leukocyte Biol 1994, 55:682-684
26. Mukherjee J, Casadevall A, Scharff MD: Molecular characterization of the antibody responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med 1993, 177:1105-1106
27. Lovchik JA, Lyons CR, Lipscomb MF: A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am J Respir Cell Mol Biol 1995, 13:116-124